AAAAAA

   
Results: 1-25 | 26-50 | 51-67
Results: 1-25/67
P21(WAF1 CIP1) AND TRANSFORMING-GROWTH-FACTOR BETA-1 PROTEIN EXPRESSION CORRELATE WITH SURVIVAL IN NONSMALL CELL LUNG-CANCER/
Authors: BENNETT WP ELDEIRY WS RUSH WL GUINEE DG FREEDMAN AN CAPORASO NE WELSH JA JONES RT BORKOWSKI A TRAVIS WD FLEMING MV TRASTEK V PAIROLERO PC TAZELAAR HD MIDTHUN D JETT JR LIOTTA LA HARRIS CC
Citation: Wp. Bennett et al., P21(WAF1 CIP1) AND TRANSFORMING-GROWTH-FACTOR BETA-1 PROTEIN EXPRESSION CORRELATE WITH SURVIVAL IN NONSMALL CELL LUNG-CANCER/, Clinical cancer research, 4(6), 1998, pp. 1499-1506
P53 MUTATIONS IN CYCLOPHOSPHAMIDE-ASSOCIATED BLADDER-CANCER
Authors: KHAN MA TRAVIS LB LYNCH CF SOINI Y HRUSZKEWYCZ AM DELGADO RM HOLOWATY EJ VANLEEUWEN FE GLIMELIUS B STOVALL M BOICE JD TARONE RE BENNETT WP
Citation: Ma. Khan et al., P53 MUTATIONS IN CYCLOPHOSPHAMIDE-ASSOCIATED BLADDER-CANCER, Cancer epidemiology, biomarkers & prevention, 7(5), 1998, pp. 397-403
LOSS OF HETEROZYGOSITY IN SPORADIC ESOPHAGEAL TUMORS IN THE TYLOSIS ESOPHAGEAL CANCER (TOC) GENE REGION OF CHROMOSOME 17Q
Authors: VONBREVERN M HOLLSTEIN MC RISK JM GARDE J BENNETT WP HARRIS CC MUEHLBAUER KR FIELD JK
Citation: M. Vonbrevern et al., LOSS OF HETEROZYGOSITY IN SPORADIC ESOPHAGEAL TUMORS IN THE TYLOSIS ESOPHAGEAL CANCER (TOC) GENE REGION OF CHROMOSOME 17Q, Oncogene, 17(16), 1998, pp. 2101-2105
HSMAD5 GENE, A HUMAN HSMAD FAMILY MEMBER - ITS FULL-LENGTH CDNA, GENOMIC STRUCTURE, PROMOTER REGION AND MUTATION ANALYSIS IN HUMAN TUMORS
Authors: GEMMA A HAGIWARA K VINCENT F KE Y HANCOCK AR NAGASHIMA M BENNETT WP HARRIS CC
Citation: A. Gemma et al., HSMAD5 GENE, A HUMAN HSMAD FAMILY MEMBER - ITS FULL-LENGTH CDNA, GENOMIC STRUCTURE, PROMOTER REGION AND MUTATION ANALYSIS IN HUMAN TUMORS, Oncogene, 16(7), 1998, pp. 951-956
MUTATION ANALYSIS OF THE SMAD2 GENE IN HUMAN COLON CANCERS USING GENOMIC DNA AND INTRON PRIMERS
Authors: TAKENOSHITA S TANI M MOGI A NAGASHIMA M NAGAMACHI Y BENNETT WP HAGIWARA K HARRIS CC YOKOTA J
Citation: S. Takenoshita et al., MUTATION ANALYSIS OF THE SMAD2 GENE IN HUMAN COLON CANCERS USING GENOMIC DNA AND INTRON PRIMERS, Carcinogenesis, 19(5), 1998, pp. 803-807
BCL-2 IMMUNOHISTOCHEMISTRY IN A SURGICAL SERIES OF NONSMALL CELL LUNG-CANCER PATIENTS
Authors: FLEMING MV GUINEE DG CHU WS FREEDMAN AN CAPORASO NE BENNETT WP COLBY TV TAZELAAR H ABBONDANZO SL JETT J PAIROLERO P TRASTEK V LIOTTA LA HARRIS CC TRAVIS WD
Citation: Mv. Fleming et al., BCL-2 IMMUNOHISTOCHEMISTRY IN A SURGICAL SERIES OF NONSMALL CELL LUNG-CANCER PATIENTS, Human pathology, 29(1), 1998, pp. 60-64
UP-REGULATION OF INDUCIBLE NITRIC-OXIDE SYNTHASE EXPRESSION IN CANCER-PRONE P53 KNOCKOUT MICE
Authors: AMBS S OGUNFUSIKA MO MERRIAM WG BENNETT WP BILLIAR TR HARRIS CC
Citation: S. Ambs et al., UP-REGULATION OF INDUCIBLE NITRIC-OXIDE SYNTHASE EXPRESSION IN CANCER-PRONE P53 KNOCKOUT MICE, Proceedings of the National Academy of Sciences of the United Statesof America, 95(15), 1998, pp. 8823-8828
ANTI-P53 ANTIBODIES IN PATIENTS WITH BARRETTS-ESOPHAGUS OR ESOPHAGEAL-CARCINOMA CAN PREDATE CANCER-DIAGNOSIS
Authors: CAWLEY HM MELTZER SJ DEBENEDETTI VMG HOLLSTEIN MC MUEHLBAUER KR LIANG L BENNETT WP SOUZA RF GREENWALD BD COTTRELL J SALABES A BARTSCH H TRIVERS GE
Citation: Hm. Cawley et al., ANTI-P53 ANTIBODIES IN PATIENTS WITH BARRETTS-ESOPHAGUS OR ESOPHAGEAL-CARCINOMA CAN PREDATE CANCER-DIAGNOSIS, Gastroenterology, 115(1), 1998, pp. 19-27
FREQUENT NITRIC-OXIDE SYNTHASE-2 EXPRESSION IN HUMAN COLON ADENOMAS -IMPLICATION FOR TUMOR ANGIOGENESIS AND COLON-CANCER PROGRESSION
Authors: AMBS S MERRIAM WG BENNETT WP FELLEYBOSCO E OGUNFUSIKA MO OSER SM KLEIN S SHIELDS PG BILLIAR TR HARRIS CC
Citation: S. Ambs et al., FREQUENT NITRIC-OXIDE SYNTHASE-2 EXPRESSION IN HUMAN COLON ADENOMAS -IMPLICATION FOR TUMOR ANGIOGENESIS AND COLON-CANCER PROGRESSION, Cancer research, 58(2), 1998, pp. 334-341
ALLELIC DELETION ANALYSIS OF THE FHIT GENE PREDICTS POOR SURVIVAL IN NONSMALL CELL LUNG-CANCER
Authors: BURKE L KHAN MA FREEDMAN AN GEMMA A RUSIN M GUINEE DG BENNETT WP CAPORASO NE FLEMING MV TRAVIS WD COLBY TV TRASTEK V PAIROLERO PC TAZELAAR HD MIDTHUN DE LIOTTA LA HARRIS CC
Citation: L. Burke et al., ALLELIC DELETION ANALYSIS OF THE FHIT GENE PREDICTS POOR SURVIVAL IN NONSMALL CELL LUNG-CANCER, Cancer research, 58(12), 1998, pp. 2533-2536
VASCULAR ENDOTHELIAL GROWTH-FACTOR AND NITRIC-OXIDE SYNTHASE EXPRESSION IN HUMAN LUNG-CANCER AND THE RELATION TO P53
Authors: AMBS S BENNETT WP MERRIAM WG OGUNFUSIKA MO OSER SM KHAN MA JONES RT HARRIS CC
Citation: S. Ambs et al., VASCULAR ENDOTHELIAL GROWTH-FACTOR AND NITRIC-OXIDE SYNTHASE EXPRESSION IN HUMAN LUNG-CANCER AND THE RELATION TO P53, British Journal of Cancer, 78(2), 1998, pp. 233-239
P53 MUTATIONS IN ESOPHAGEAL TUMORS FROM A HIGH-INCIDENCE AREA OF CHINA IN RELATION TO PATIENT DIET AND SMOKING HISTORY
Authors: BENNETT WP VONBREVERN MC ZHU SM BARTSCH H MUEHLBAUER KR HOLLSTEIN MC
Citation: Wp. Bennett et al., P53 MUTATIONS IN ESOPHAGEAL TUMORS FROM A HIGH-INCIDENCE AREA OF CHINA IN RELATION TO PATIENT DIET AND SMOKING HISTORY, Cancer epidemiology, biomarkers & prevention, 6(11), 1997, pp. 963-966
MUTATION ANALYSIS OF THE TRANSFORMING GROWTH-FACTOR-BETA TYPE-II RECEPTOR IN HUMAN CELL-LINES RESISTANT TO GROWTH-INHIBITION BY TRANSFORMING GROWTH-FACTOR-BETA
Authors: VINCENT F NAGASHIMA M TAKENOSHITA S KHAN MA GEMMA A HAGIWARA K BENNETT WP
Citation: F. Vincent et al., MUTATION ANALYSIS OF THE TRANSFORMING GROWTH-FACTOR-BETA TYPE-II RECEPTOR IN HUMAN CELL-LINES RESISTANT TO GROWTH-INHIBITION BY TRANSFORMING GROWTH-FACTOR-BETA, Oncogene, 15(1), 1997, pp. 117-122
MUTATION ANALYSIS OF CODING SEQUENCES OF THE ENTIRE TRANSFORMING GROWTH-FACTOR-BETA TYPE-II RECEPTOR GENE IN SPORADIC HUMAN COLON-CANCER USING GENOMIC DNA AND INTRON PRIMERS
Authors: TAKENOSHITA S TANI M NAGASHIMA M HAGIWARA K BENNETT WP YOKOTA J HARRIS CC
Citation: S. Takenoshita et al., MUTATION ANALYSIS OF CODING SEQUENCES OF THE ENTIRE TRANSFORMING GROWTH-FACTOR-BETA TYPE-II RECEPTOR GENE IN SPORADIC HUMAN COLON-CANCER USING GENOMIC DNA AND INTRON PRIMERS, Oncogene, 14(10), 1997, pp. 1255-1258
DIFFERENTIAL-EFFECTS OF P53 MUTANTS ON THE GROWTH OF HUMAN BRONCHIAL EPITHELIAL-CELLS
Authors: COURSEN JD BENNETT WP KHAN MA FORRESTER K PIETENPOL JA HARRIS CC
Citation: Jd. Coursen et al., DIFFERENTIAL-EFFECTS OF P53 MUTANTS ON THE GROWTH OF HUMAN BRONCHIAL EPITHELIAL-CELLS, Molecular carcinogenesis, 19(3), 1997, pp. 191-203
ABSENCE OF MUTATIONS IN THE TRANSFORMING GROWTH-FACTOR-BETA TYPE-II RECEPTOR IN SPORADIC LUNG CANCERS WITH MICROSATELLITE INSTABILITY AND RARE H-RAS1 ALLELES
Authors: TAKENOSHITA S HAGIWARA K GEMMA A NAGASHIMA M RYBERG D LINDSTEDT BA BENNETT WP HAUGEN A HARRIS CC
Citation: S. Takenoshita et al., ABSENCE OF MUTATIONS IN THE TRANSFORMING GROWTH-FACTOR-BETA TYPE-II RECEPTOR IN SPORADIC LUNG CANCERS WITH MICROSATELLITE INSTABILITY AND RARE H-RAS1 ALLELES, Carcinogenesis, 18(7), 1997, pp. 1427-1429
SERUM, PLASMA AND PARAFFIN-EMBEDDED TISSUES AS SOURCES OF DNA FOR STUDYING CANCER SUSCEPTIBILITY GENES
Authors: BLOMEKE B BENNETT WP HARRIS CC SHIELDS PG
Citation: B. Blomeke et al., SERUM, PLASMA AND PARAFFIN-EMBEDDED TISSUES AS SOURCES OF DNA FOR STUDYING CANCER SUSCEPTIBILITY GENES, Carcinogenesis, 18(6), 1997, pp. 1271-1275
SPORADIC AND THOROTRAST-INDUCED ANGIOSARCOMAS OF THE LIVER MANIFEST FREQUENT AND MULTIPLE POINT MUTATIONS IN K-RAS-2
Authors: PRZYGODZKI RM FINKELSTEIN SD KEOHAVONG P ZHU D BAKKER A SWALSKY PA SOINI Y ISHAK KG BENNETT WP
Citation: Rm. Przygodzki et al., SPORADIC AND THOROTRAST-INDUCED ANGIOSARCOMAS OF THE LIVER MANIFEST FREQUENT AND MULTIPLE POINT MUTATIONS IN K-RAS-2, Laboratory investigation, 76(1), 1997, pp. 153-159
GENOMIC INSTABILITY AND TELOMERASE ACTIVITY IN HUMAN BRONCHIAL EPITHELIAL-CELLS DURING IMMORTALIZATION BY HUMAN PAPILLOMAVIRUS-16 E6 AND E7GENES
Authors: COURSEN JD BENNETT WP GOLLAHON L SHAY JW HARRIS CC
Citation: Jd. Coursen et al., GENOMIC INSTABILITY AND TELOMERASE ACTIVITY IN HUMAN BRONCHIAL EPITHELIAL-CELLS DURING IMMORTALIZATION BY HUMAN PAPILLOMAVIRUS-16 E6 AND E7GENES, Experimental cell research, 235(1), 1997, pp. 245-253
FHIT MUTATIONS IN HUMAN PRIMARY GASTRIC-CANCER
Authors: GEMMA A HAGIWARA K KE Y BURKE LM NAGASHIMA HAKM BENNETT WP HARRIS CC
Citation: A. Gemma et al., FHIT MUTATIONS IN HUMAN PRIMARY GASTRIC-CANCER, Cancer research, 57(8), 1997, pp. 1435-1437
INTEGRITY OF P53 IN HEPATITIS-B X-ANTIGEN-POSITIVE AND X-ANTIGEN-NEGATIVE HEPATOCELLULAR CARCINOMAS
Authors: GREENBLATT MS FEITELSON MA ZHU M BENNETT WP WELSH JA JONES R BORKOWSKI A HARRIS CC
Citation: Ms. Greenblatt et al., INTEGRITY OF P53 IN HEPATITIS-B X-ANTIGEN-POSITIVE AND X-ANTIGEN-NEGATIVE HEPATOCELLULAR CARCINOMAS, Cancer research, 57(3), 1997, pp. 426-432
RE - LUNG-CANCER AFTER HODGKINS-DISEASE - RESPONSE
Authors: TRAVIS LB CURTIS RE BENNETT WP HANKEY BF BOICE JD TRAVIS WD
Citation: Lb. Travis et al., RE - LUNG-CANCER AFTER HODGKINS-DISEASE - RESPONSE, Journal of the National Cancer Institute, 88(1), 1996, pp. 52-52
ANTI-P53 ANTIBODIES IN SERA FROM PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE CAN PREDATE A DIAGNOSIS OF CANCER
Authors: TRIVERS GE DEBENEDETTI VMG CAWLEY HL CARON G HARRINGTON AM BENNETT WP JETT JR COLBY TV TAZELAAR H PAIROLERO P MILLER RD HARRIS CC
Citation: Ge. Trivers et al., ANTI-P53 ANTIBODIES IN SERA FROM PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE CAN PREDATE A DIAGNOSIS OF CANCER, Clinical cancer research, 2(10), 1996, pp. 1767-1775
P53 MUTATIONS IN LUNG-CANCER FOLLOWING RADIATION-THERAPY FOR HODGKINS-DISEASE
Authors: DEBENEDETTI VMG TRAVIS LB WELSH JA VANLEEUWEN FE STOVALL M CLARKE EA BOICE JD BENNETT WP
Citation: Vmg. Debenedetti et al., P53 MUTATIONS IN LUNG-CANCER FOLLOWING RADIATION-THERAPY FOR HODGKINS-DISEASE, Cancer epidemiology, biomarkers & prevention, 5(2), 1996, pp. 93-98
P53 MUTATIONS AND OCCUPATIONAL EXPOSURES IN A SURGICAL SERIES OF LUNGCANCERS
Authors: HARTY LC GUINEE DG TRAVIS WD BENNETT WP JETT J COLBY TV TAZELAAR H TRASTEK V PAIROLERO P LIOTTA LA HARRIS CC CAPORASO NE
Citation: Lc. Harty et al., P53 MUTATIONS AND OCCUPATIONAL EXPOSURES IN A SURGICAL SERIES OF LUNGCANCERS, Cancer epidemiology, biomarkers & prevention, 5(12), 1996, pp. 997-1003
Risultati: 1-25 | 26-50 | 51-67